Jeffrey E. Jacob - 27 Mar 2023 Form 4 Insider Report for Panbela Therapeutics, Inc. (PBLA)

Role
Director
Signature
/s/ Joshua L. Colburn, Attorney-in-Fact
Issuer symbol
PBLA
Transactions as of
27 Mar 2023
Transactions value $
$0
Form type
4
Filing time
29 Mar 2023, 16:21:19 UTC
Previous filing
06 Oct 2022
Next filing
14 Sep 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PBLA Stock Option (right to buy) Award $0 +8.33K $0.00 8.33K 27 Mar 2023 Common Stock 8.33K $0.50 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options scheduled to vest on the earlier of day before annual meeting of stockholders or one year anniversary.